123 related articles for article (PubMed ID: 9636464)
1. Effect of Sandimmune cyclosporine on renal blood flow and function in heart transplant recipients.
Chung G; Walker S; Vadher B; Murphy F; Leaver N; Banner N
Transplant Proc; 1998 Jun; 30(4):1147-8. PubMed ID: 9636464
[No Abstract] [Full Text] [Related]
2. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
Lloveras JJ; Durand D; Ader JL; Tran Van T; Rostaing L; Cerene A; Fournial G; Suc JM
Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
[No Abstract] [Full Text] [Related]
3. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
Cooney GF; Jeevanandam V; Choudhury S; Feutren G; Mueller EA; Eisen HJ
Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
[No Abstract] [Full Text] [Related]
4. Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine.
Sahar G; Berman M; Ben-Gal T; Sahar E; Kogan A; Michowitch R; Saute M; Kramer M; Sagie A; Shapira Y; Aravot D; Vidne BA
Transplant Proc; 2003 Mar; 35(2):678. PubMed ID: 12644092
[No Abstract] [Full Text] [Related]
5. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G
Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229
[No Abstract] [Full Text] [Related]
7. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ
J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913
[TBL] [Abstract][Full Text] [Related]
8. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
[No Abstract] [Full Text] [Related]
9. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
10. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
[No Abstract] [Full Text] [Related]
11. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
Steinmuller D; Dougherty J; Coutee J; Surek D; Swies G; Lewis R
Transplant Proc; 1997; 29(1-2):298-9. PubMed ID: 9123005
[No Abstract] [Full Text] [Related]
12. Cyclosporine-induced transient renal hypoperfusion in adolescent transplant recipients.
Dello Strologo L; Massella L; Rizzoni G
Pediatr Nephrol; 1996 Feb; 10(1):81-3. PubMed ID: 8611366
[TBL] [Abstract][Full Text] [Related]
13. Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.
Hansen JM; Fogh-Andersen N; Leyssac PP; Strandgaard S
Nephron; 1998 Dec; 80(4):450-7. PubMed ID: 9832645
[TBL] [Abstract][Full Text] [Related]
14. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
[No Abstract] [Full Text] [Related]
15. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
Wilczek HE; Akesson P; Warholm C
Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
[No Abstract] [Full Text] [Related]
16. Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine.
Ruggenenti P; Perico N; Amuchastegui CS; Ferrazzi P; Mamprin F; Remuzzi G
Am J Kidney Dis; 1994 Oct; 24(4):549-53. PubMed ID: 7942808
[TBL] [Abstract][Full Text] [Related]
17. Follow-up after conversion to Neoral in stable heart transplant recipients.
Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T
Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
[No Abstract] [Full Text] [Related]
18. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of Neoral in thoracic organ transplantation.
Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N
Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326
[No Abstract] [Full Text] [Related]
20. Development of severe adverse effects after discontinuing amiodarone therapy in human heart transplant recipients.
Preuner JG; Lehle K; Keyser A; Merk J; Rupprecht L; Goebels R
Transplant Proc; 1998 Dec; 30(8):3943-4. PubMed ID: 9865253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
